- Gartner hype cycle technology 2021 drivers#
- Gartner hype cycle technology 2021 registration#
- Gartner hype cycle technology 2021 software#
Gartner, “Hype Cycle for Life Science Research and Development, 2021”, Jeff Smith, Michael Shanler, 19 July 2021
“We continue to look forward to advance technologies that drive solutions for how clinical study and medical data, content and information is constructed and deconstructed, managed and distributed across healthcare ecosystems that streamline getting new therapies to patients.” “We believe this is an honor for Gartner to recognize how Anju is addressing areas critical to the continued growth of the life sciences sector,” said Suhas Gudihal, Chief Innovation Officer, Anju Software. The Gartner report states that “ Key Opinion Leader (KOL) systems are used to identify and build relationships with individuals who are influential in shaping peer healthcare providers’ (HCPs’) views on therapies.” The report further highlights that “ Life science organizations’ adoption of KOL solutions is necessary as more scientifically complex and high-priced products enter the marketplace.” Structured Content Authoring (SCA) and Component-Based Authoring (CBA) “ that are the technologies and processes of managing data and content captured in activities used in life science regulatory filings.” Further the report states, “It decomposes documents, data and other content into discrete components that can be flexibly used and reassembled into different end requirements and change managed, resulting in greater activity and control for life sciences companies operating in complex, global regulatory frameworks.”Īdditionally, in Gartner’s Hype Cycle for Life Science Commercial Operations report, Anju was recognized as a sample vendor of “Key Opinion Leader Management”.
Gartner hype cycle technology 2021 registration#
Clinical Trial Data Transparency (CTDT) which includes “tools and solutions for trial data redaction, anonymization, web portals and data storage and hosting, and trial registration with authorities, among other CTDT requirements.” e-Clinical Platforms that “support the end-to-end needs of clinical trial planning and execution and are composed of integrated solutions used for protocol development, electronic data capture (EDC), clinical trial management systems (CTMSs), randomization and trial supply management systems (RTSMs), electronic trial master files (eTMF), trial analytics and reports, and related capabilities that support clinical trial operations.”
Gartner hype cycle technology 2021 drivers#
Additionally, in their Priority Matrix for Life Science Research and Development 2021, Gartner recognized three areas - e-Clinical Platforms, Clinical Trial Data Transparency (CTDT), and Structured Content Authoring (SBA) and Component Authoring (CBA) – as drivers impacting the digital acceleration of life sciences with the best opportunities to invest in within the next 2 to 5 years for mainstream adoption.Īccording to the Gartner Hype Cycle for Life Science Research and Development report, Anju is cited particularly in the following categories: In the R&D space, Anju was named in the “e-Clinical platforms” category, which Gartner recognized as having a “transformational benefit” in their Priority Matrix for Life Science Research and Development, 2021.
Gartner hype cycle technology 2021 software#
Anju Software has also been recognized in the “Key Opinion Leader Management” category in the Gartner Hype Cycle for Life Science Commercial Operations, 2021. Anju’s work providing advanced software technology solutions across the clinical and commercial functions of life sciences was recognized in the “e-Clinical Platforms,” “Clinical Trial Data Transparency,” “Structured Content and Component Authoring” and “Key Opinion Leader Management” sections of the reports. LAUDERDALE, Fla.-( BUSINESS WIRE)-Anju Software has been named by Gartner as a sample vendor in four categories in its 2021 Hype Cycle Life Sciences Research and Development report and Commercial Operations report.